Altria reported fourth-quarter adjusted earnings of $1.30 per share, falling short of the consensus estimate of $1.32. While this represents a modest increase from the $1.29 earned in the year-ago period, the 1.5% earnings beat threshold was not met. Operating income for the segment declined 2% year-over-year, reflecting a 1.8% drop in shipment volumes as consumers reacted to higher retail prices.

Net revenue in the quarter rose 4.2% to $6.0 billion, compared with $5.76 billion a year earlier. This growth was driven entirely by an average 5.1% price increase on Marlboro cigarettes and oral tobacco products. Unit volume declines of 1.8% offset some of the benefit, but Altria’s management highlighted that sequential momentum in retail pricing continued into January 2026.

Altria guided 2026 adjusted earnings per share to a range of $5.15 to $5.25, exceeding the current consensus of $5.10. The company plans additional price increases of 5% to 6% on its core tobacco portfolio, expecting these actions to offset a low-single-digit volume decline. Management also reiterated plans to return at least 80% of free cash flow to shareholders through dividends and share repurchases.

At year-end, Altria held $3.8 billion in net debt and boasted an investment-grade credit rating of BBB+. Free cash flow for the quarter reached $1.2 billion, up 3% from last year, driven by disciplined working capital management. The board approved a 4.4% increase in the quarterly dividend to $0.98 per share, marking the 52nd consecutive year of dividend growth.